TracerDX, Inc. — Form D
TracerDX, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-08. The offering totals $9.0M, of which $7.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-08-08
- Form: D
- Accession: 0002033011-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $9.0M
- Amount sold: $7.9M
- Remaining: $1.1M
- Investors: 18
- Date of first sale: 2024-07-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-520952
Issuer
- Name: TracerDX, Inc.
- CIK: 0002033011
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 180 VARICK ST., FLOOR 6, NEW YORK, NY, 10014
- Phone: 561-365-8764
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Mark Kaganovich | Director | New York, NY |
| Mark Kaganovich | Executive Officer | New York, NY |
More